Leukemia: all 5,475 studies
Page 28 of 55. Open to participants first (629), then studies with results posted, then the rest; newest registration first within each.
- Combination of BTK Inhibitor Overcomes Drug-resistance in Refractory/Relapsed FLT3 Mutant AMLStatus unknownNCT03642236Phase 2/3
- Rituximab, Idelalisib, and Venetoclax in Relapsed/Refractory CLL/SLLWithdrawnNCT03639324Phase 1
- Autologous CAR-T/TCR-T Cell Immunotherapy for MalignanciesStatus unknownNCT03638206Phase 1/2
- Observational Study of Ibrutinib Use in CLLStatus unknownNCT03633045
- Tisagenlecleucel vs Blinatumomab or Inotuzumab for Patients With Relapsed/Refractory B-cell Precursor Acute Lymphoblastic LeukemiaWithdrawnNCT03628053Phase 3
- Optimal Methods of Disease Detection in Children and Young Adults With Acute Lymphoblastic Leukemia in the Pediatric Oncology BranchCompletedNCT03627208
- The Hong Kong CML RegistryStatus unknownNCT03625583
- A Study to Assess Safety and Efficacy of Venetoclax in Combination With Gilteritinib in Participants With Relapsed/Refractory Acute Myeloid LeukemiaCompletedNCT03625505Phase 1
- Low Dose Dasatinib (50 mg Daily) as First-line Treatment for Newly Diagnosed Chronic-Phase Chronic Myeloid LeukemiaCompletedNCT03625388Phase 2
- Production of Clinical-grade Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory B-cell MalignanciesStatus unknownNCT03624686
- Effect of Prophylactic TKI Therapy Post-transplants on Ph+ ALL Undergoing Allo-HSCT With MRD Positive Pre-transplantsStatus unknownNCT03624530Phase 2/3
- Oral Arsenic Trioxide for Newly Diagnosed Acute Promyelocytic LeukaemiaStatus unknownNCT03624270Phase 2
- Study to Determine the Efficacy of Uproleselan (GMI-1271) in Combination With Chemotherapy to Treat Relapsed/Refractory Acute Myeloid LeukemiaTerminatedNCT03616470Phase 3
- Ruxolitinib Plus LVP in Patients With R/R ETP-ALLStatus unknownNCT03613428Phase 1/2
- Dexamethasone Added to Intensive Chemotherapy in Older Patients with Acute Myeloid Leukemia (AML)Active, not recruitingNCT03609060Phase 2
- Pembro + Blina Combination in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Leukemia or LymphomaWithdrawnNCT03605589Phase 1
- Study Impact on Outcome of Eltrombopag in Elderly Patients with Acute Myeloid Leukemia Receiving Induction ChemotherapyActive, not recruitingNCT03603795Phase 2
- Comparing ATG or Post-Transplant Cyclophosphamide to Calcineurin Inhibitor-Methotrexate as GVHD Prophylaxis After Myeloablative Unrelated Donor Peripheral Blood Stem Cell TransplantationWithdrawnNCT03602898Phase 2
- Efficacy of FLAG Regimen for the Treatment of Patients With AMLStatus unknownNCT03600558
- Management of Mixed-Phenotype Acute Leukemia in the East of FranceStatus unknownNCT03599869
- Immunotherapy With CD19 CART-cells for B Cell Acute Lymphoblastic LeukemiaStatus unknownNCT03599375Phase 1
- Decitabine+BUCY vs BUCY Conditioning Regimen for MLL+ Acute Leukemia Undergoing Allo-HSCTStatus unknownNCT03596892Phase 2/3
- Association Between Mitochondrial DNA Content and Risk of Acute LeukemiaCompletedNCT03595969
- COaching and Prehabilitation: Faisability Study in Patients With Acute Myeloid Leukemia and Myelodysplastic SyndromeActive, not recruitingNCT03595787Not applicable
- Evaluate the Neuroprotective Effect of Vitamin B6 and Vitamin B12 Against Vincristine Induced Neurotoxicity in Acute Lymphoblastic Leukaemia PatientsCompletedNCT03593304Phase 2/3
- Nivolumab and Tocilizumab for Relapsed Hematological Malignancy Post-allogeneic TransplantTerminatedNCT03588936Phase 1
- A Study on the Uterus, Ovarian and Reproductive Functions According to Conditioning Regimen and Pubertal Status at the Time of Stem Cell Transplantation in a Leukemia Pediatric PopulationStatus unknownNCT03583294Not applicable
- Clinical Outcomes and Routine Management of Adults With Chronic Lymphocytic Leukaemia Treated With Idelalisib and Rituximab in the United Kingdom (UK) and IrelandCompletedNCT03582098
- Postural Control Under Different Cognitive Loads in Adult Survivors of Acute Lymphoblastic Leukemia and Age-Matched Healthy IndividualsCompletedNCT03581045
- CD19-Specific T Cells Post AlloSCTTerminatedNCT03579888Phase 1
- CD19-CAR-T Cells in Patients With R/R B-ALLStatus unknownNCT03574168Phase 1
- Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult T-LBL/ALLStatus unknownNCT03564704Phase 2/3
- Precision Diagnosis Directing HDACi and TKI Target Therapy for Adult Ph-like ALLStatus unknownNCT03564470Phase 2/3
- Study to Find a Safe and Effective Dose of SKI-G-801 in the Treatment of Patients With Acute Myeloid Leukemia (AML)CompletedNCT03564288Phase 1
- A Study of DSP-2033 (Alvocidib) in Patients With Acute Myeloid LeukemiaCompletedNCT03563560Phase 1
- Dasatinib Combined With Chemotherapy in Relapsed t(8;21) Acute Myeloid Leukemia With KIT D816 MutationWithdrawnNCT03560908Phase 1
- Patient-individualized Peptide Vaccination Based on Tumor-specific Mutations in Children and Young Adults With Primary/Relapsed ALLCompletedNCT03559413Phase 1/2
- The Role of Ruxolitinib in Secondary Acute Myelogenous Leukemia Evolving From Myeloproliferative NeoplasmStatus unknownNCT03558607Phase 1/2
- CART-123 FOR Relapsed/Refractory Acute Myelocytic Leukemia（AML）Status unknownNCT03556982Phase 1/2
- A Trial to Evaluate the Potential Impact of Renal Impairment on the Pharmacokinetics and Safety of CPX-351CompletedNCT03555955Phase 1
- Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult ETP-ALLStatus unknownNCT03553238Phase 2/3
- Evaluation of Measurable Residual Disease in Patients With Acute Myeloid Leukemia as Surrogate Endpoint for SurvivalTerminatedNCT03549351
- Childhood Acute Lymphoblastic Leukaemia: Follow-UpCompletedNCT03545659
- Efficacy and Safety in Patients With Chronic Lymphocytic Leukemia (CLL) Treated With Idelalisib and Rituximab in the Clinical Practice: a GIMEMA-ERIC StudyCompletedNCT03545035
- CART-19 FOR Relapsed/Refractory Acute Lymphoblastic Leukemia （ALL）Status unknownNCT03544021Phase 1/2
- Budget Impact Analysis of Discontinuing Tyrosin Kinase Inhibitors in Patients With Chronic Myeloid Leukemia Achieving a Complete Molecular Response by Using Probabilistic Markov ApproachCompletedNCT03540654
- Detection of IDH2 Mutations and Monitoring Molecular Residual Disease in Patients With AMLCompletedNCT03537560
- A Clinical Trial to Learn About the Study Medicine Called Maplirpacept (PF-07901801), Alone and When Used in Combination With Other Medicines to Treat Participants With Advanced Hematological Malignancies, Including Lymphoma, Leukemia and Multiple MyelomaTerminatedNCT03530683Phase 1
- Dec+Flu+Bu Conditioning Regimen for Elderly AML in CR Undergoing Allo-HSCTStatus unknownNCT03530085Phase 2/3
- Chemotherapy Efficacy and Follow-up Study of Hepatitis B Virus Infection and Reactivation in Children With LeukemiaStatus unknownNCT03529760
- The Incidence of Hepatitis B Reactivations in Patients Affected by Chronic Lymphocytic Leukemia With IbrutinibCompletedNCT03528941
- A Post-Marketing Observational Study of VYXEOS™CompletedNCT03526926
- Ascorbic Acid Levels in MDS, AML, and CMML PatientsCompletedNCT03526666
- EphB4-HSA Fusion Protein and Cytarabine /or Liposomal Vincristine in Patients With Recurrent or Refractory Acute LeukemiaTerminatedNCT03519984Phase 1
- Dose-escalating Phase I Trial With GEM333 in Patients With Acute Myeloid LeukemiaTerminatedNCT03516760Phase 1
- Stem Cell Transplant to Treat Patients With Favorable or Intermediate Risk Minimal Residual Disease Negative Acute Myeloid LeukemiaWithdrawnNCT03515707Phase 2
- Treatment With Combination Chemotherapy for Relapsed or Refractory Acute Lymphoblastic LeukemiaTerminatedNCT03515200Phase 1
- Evaluation of the Therapeutic Effect of HU Pulse Therapy for CML PatientsStatus unknownNCT03515018Phase 3
- Pembrolizumab and Blinatumomab in Treating Participants With Recurrent or Refractory Acute Lymphoblastic LeukemiaActive, not recruitingNCT03512405Phase 1/2
- Study of Chinese Newly Diagnosed Participants With Philadelphia Chromosome-Positive (Ph+) Chronic Myeloid Leukemia in Chronic Phase (CML-CP)CompletedNCT03509896
- Tolerance and Resistance to Ibrutinib in Patients With Chronic Lymphocytic Leukemia (CLLCompletedNCT03502876
- An Early Access Programme for Moxetumomab Pasudotox in Relapsed/Refractory Hairy Cell LeukemiaApproved for marketingNCT03501615
- Screening of IDH1 and IDH2 Gene Mutations in Adult Acute Myeloid Leukemia for Possible Targeted TherapyStatus unknownNCT03499912
- Chronic Lymphocytic Leukemia Responds to Dermal ChelationStatus unknownNCT03495492Not applicable
- Patient Ambassador Support in Newly Diagnosed Patients With Acute Leukemia During TreatmentCompletedNCT03493906Not applicable
- Evaluating in Vivo AZA Incorporation in Mononuclear Cells Following Vidaza or CC486CompletedNCT03493646Phase 2
- Pilot Evaluation of a Microfluidic Assay to Detect Minimal Residual Disease and Predict Relapse in AML PatientsCompletedNCT03488862
- A Study of Venetoclax and Dinaciclib (MK7965) in Patients With Relapsed/Refractory Acute Myeloid LeukemiaTerminatedNCT03484520Phase 1
- Phase I Study of HMPL-523+Azacitidine in Elderly Patients With Acute Myeloid LeukemiaTerminatedNCT03483948Phase 1
- Trial of AB-110 in Adults With Hematologic Malignancies Undergoing Cord Blood TransplantationCompletedNCT03483324Phase 1
- Clinical Outcomes of Chronic Lymphocytic Leukemia (CCL) and Mantle Cell Lymphoma (MCL) Participants Treated With Ibrutinib: A Medical Chart Review From IndiaCompletedNCT03476655
- CAR-T Cells Therapy in Relapsed/Refractory Acute Myeloid LeukemiaTerminatedNCT03473457Not applicable
- Palbociclib and Dexamethasone in Treating Participants With Relapsed or Refractory B-Cell Acute Lymphoblastic LeukemiaCompletedNCT03472573Phase 1
- Nutritional Status in Children With ALL in GuatemalaCompletedNCT03471416
- Autoimmune Cytopenia and BcR InhibitorsStatus unknownNCT03469895
- A Study of Venetoclax and Rituximab/Hyaluronidase Human in Relapsed/Refractory CLLActive, not recruitingNCT03467867Phase 2
- CD19 T-CAR for Treatment of Children and Young Adults With r/r B-ALLActive, not recruitingNCT03467256Phase 1/2
- A Feasibility and Safety Study of Concomitant Therapy With Allo-CAR-T Cells and Allo-HSCT in Patients With Relapse or Refractory LeukemiaStatus unknownNCT03463928Phase 1
- De-escalated Treatment Approach for Adult Ph-negative Acute Lymphoblastic Leukemia (ALL)Status unknownNCT03462095Not applicable
- Pevonedistat and Low Dose Cytarabine in Adult Patients With AML and MDSCompletedNCT03459859Phase 1
- Activity and Safety of Front-line Venetoclax and Rituximab in Young and Fit Patients With Chronic Lymphocytic LeukemiaCompletedNCT03455517Phase 2
- Effectiveness and Safety Study of Generic Imatinib in Chronic Myeloid Leukemia Patients in EgyptCompletedNCT03454503
- AML Electronic Decision AidCompletedNCT03442452Not applicable
- A Study of Venetoclax and Alvocidib in Patients With Relapsed/Refractory Acute Myeloid LeukemiaCompletedNCT03441555Phase 1
- Lintuzumab-Ac225 in Combination with Cladribine + Cytarabine + Filgastrim + Mitoxantrone (CLAG-M) for Relapsed/Refractory Acute Myeloid LeukemiaCompletedNCT03441048Phase 1
- Multi-antigen CMV-Modified Vaccinia Ankara Vaccine in Reducing CMV Related Complications in Patients With Blood Cancer Undergoing Donor Stem Cell TransplantWithdrawnNCT03438344Phase 2
- A Prognostic Tool for Early Stage CLLCompletedNCT03436524
- Efficacy and Safety of BST-236 in Newly Diagnosed Acute Myeloid Leukemia Patients, Unfit for Standard Induction TherapyCompletedNCT03435848Phase 2
- Survival in Patients Older Than 60 Years With Newly Diagnosed AML in SpainCompletedNCT03435341
- Peripheral Blood Stem Cell Transplantation From Family Haploidentical Donors in Patients With Myelodysplastic Syndrome and Acute Leukemia Under Primary Prophylaxis With PosaconazoleCompletedNCT03434704Phase 2
- Observational Study of Spatio-Temporal Patterns of New Cases of Acute Myeloid LeukemiaCompletedNCT03433521
- PET/CT and Bacterial/Fungal PCR in High Risk Febrile NeutropeniaCompletedNCT03429387Not applicable
- A Study of Ibrutinib in the Treatment of Chronic Lymphocytic Leukemia and Mantle-cell Lymphoma in Routine Clinical PracticeCompletedNCT03425591
- Clinical Evaluation of a Test for Monitoring Patients Diagnosed With Chronic Myeloid Leukemia (CML)CompletedNCT03421626
- Evaluation of ETC-1907206 With Dasatinib in Advanced Haematologic MalignanciesWithdrawnNCT03414450Phase 1
- Evaluation of ClearLLab Leukemia and Lymphoma PanelsCompletedNCT03413644
- MAX-40279 in Subjects With Acute Myelogenous Leukemia (AML)Status unknownNCT03412292Phase 1
- A Phase II Study of the BRAF Inhibitor, Vemurafenib, Plus Obinutuzumab in Patients With Previously Untreated Classical Hairy Cell LeukemiaActive, not recruitingNCT03410875Phase 2
- Central Nervous System (CNS) Involvement in Acute Myeloid Leukemia (AML)TerminatedNCT03410407
- Early Access Program (EAP) of Gilteritinib (ASP2215) in Patients With FMS-like Tyrosine Kinase 3 (FLT3) Mutated Relapsed or Refractory Acute Myeloid Leukemia (AML) or With FLT3-Mutated AML in Complete Remission (CR) With Minimal Residual Disease (MRD)No longer availableNCT03409081